TARS

Tarsus Pharmaceuticals, Inc.

Healthcare›Biotechnology|NASDAQ Global Select|US

Price

$70.12

Market Cap

$2.98B

Beta

0.63

P/E

0.0

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+146.71%

EPS Growth (YoY)+47.74%

Revenue CAGR 3Y+159.54%

P/E Ratio0.0

PEG Ratio—

FCF Yield-0.75%

Debt / Equity0.27

Interest Coverage-11.1x

No credit card required

Already have an account? Sign in to view the full analysis for TARS.